318 related articles for article (PubMed ID: 12097994)
1. Pimecrolimus 1% cream (Elidel) for atopic dermatitis.
Bernard LA; Bergman JN; Eichenfield LF
Skin Therapy Lett; 2002 Apr; 7(4):1-3. PubMed ID: 12097994
[TBL] [Abstract][Full Text] [Related]
2. Pimecrolimus in dermatology: atopic dermatitis and beyond.
Gisondi P; Ellis CN; Girolomoni G
Int J Clin Pract; 2005 Aug; 59(8):969-74. PubMed ID: 16033622
[TBL] [Abstract][Full Text] [Related]
3. Pimecrolimus cream 1%: a new development in nonsteroid topical treatment of inflammatory skin diseases.
Hebert AA; Warken KA; Cherill R
Semin Cutan Med Surg; 2001 Dec; 20(4):260-7. PubMed ID: 11770913
[TBL] [Abstract][Full Text] [Related]
4. Topical pimecrolimus (Elidel) for treatment of atopic dermatitis.
Med Lett Drugs Ther; 2002 May; 44(1131):48-50. PubMed ID: 12045753
[No Abstract] [Full Text] [Related]
5. Pimecrolimus in dermatology.
Fabroni C; Lotti T
G Ital Dermatol Venereol; 2009 Jun; 144(3):321-5. PubMed ID: 19528913
[TBL] [Abstract][Full Text] [Related]
6. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
Hebert AA
Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
Murrell DF; Calvieri S; Ortonne JP; Ho VC; Weise-Riccardi S; Barbier N; Paul CF
Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
[TBL] [Abstract][Full Text] [Related]
8. Pimecrolimus: a review of pre-clinical and clinical data.
Graham-Brown RA; Grassberger M
Int J Clin Pract; 2003 May; 57(4):319-27. PubMed ID: 12800465
[TBL] [Abstract][Full Text] [Related]
9. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial.
Gollnick H; Kaufmann R; Stough D; Heikkila H; Andriano K; Grinienko A; Jimenez P;
Br J Dermatol; 2008 May; 158(5):1083-93. PubMed ID: 18341665
[TBL] [Abstract][Full Text] [Related]
10. Topical tacrolimus and pimecrolimus: future directions.
Ling MR
Semin Cutan Med Surg; 2001 Dec; 20(4):268-74. PubMed ID: 11770914
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants.
Ho VC; Gupta A; Kaufmann R; Todd G; Vanaclocha F; Takaoka R; Fölster-Holst R; Potter P; Marshall K; Thurston M; Bush C; Cherill R
J Pediatr; 2003 Feb; 142(2):155-62. PubMed ID: 12584537
[TBL] [Abstract][Full Text] [Related]
12. Spotlight on topical pimecrolimus in pediatric atopic dermatitis.
Yang LP; Curran MP
Am J Clin Dermatol; 2010; 11(4):295-8. PubMed ID: 20509720
[TBL] [Abstract][Full Text] [Related]
13. Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis.
Hoetzenecker W; Ecker R; Kopp T; Stuetz A; Stingl G; Elbe-Bürger A
J Allergy Clin Immunol; 2005 Jun; 115(6):1276-83. PubMed ID: 15940147
[TBL] [Abstract][Full Text] [Related]
14. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
[TBL] [Abstract][Full Text] [Related]
15. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.
McKenna SP; Whalley D; de Prost Y; Staab D; Huels J; Paul CF; van Assche D
J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):248-54. PubMed ID: 16503881
[TBL] [Abstract][Full Text] [Related]
16. Pimecrolimus. Novartis.
Schopf RE
Curr Opin Investig Drugs; 2002 May; 3(5):720-4. PubMed ID: 12090545
[TBL] [Abstract][Full Text] [Related]
17. Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients.
Eichenfield LF; Thaci D; de Prost Y; Puig L; Paul C
Dermatology; 2007; 215 Suppl 1():3-17. PubMed ID: 18174689
[TBL] [Abstract][Full Text] [Related]
18. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
de Bruin-Weller MS; Bruijnzeel-Koomen CA
Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135
[TBL] [Abstract][Full Text] [Related]
19. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
[TBL] [Abstract][Full Text] [Related]
20. Atopic dermatitis: a new treatment paradigm using pimecrolimus.
Weinberg JM; Bowerman JG; Brown SM; Gerstein D; Kane KS; Selevan J; Virdee S
J Drugs Dermatol; 2003 Apr; 2(2):131-40. PubMed ID: 12852364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
